<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JBC</journal-id>
<journal-id journal-id-type="hwp">spjbc</journal-id>
<journal-title>Journal of Bioactive and Compatible Polymers</journal-title>
<issn pub-type="ppub">0883-9115</issn>
<issn pub-type="epub">1530-8030</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0883911513484205</article-id>
<article-id pub-id-type="publisher-id">10.1177_0883911513484205</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cartilage tissue engineering with controllable shape using a poly(lactic-<italic>co</italic>-glycolic acid)/collagen hybrid scaffold</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Dai</surname><given-names>Wenda</given-names></name>
<xref ref-type="aff" rid="aff1-0883911513484205">1</xref>
<xref ref-type="aff" rid="aff2-0883911513484205">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Yao</surname><given-names>Zhenjun</given-names></name>
<xref ref-type="aff" rid="aff1-0883911513484205">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Dong</surname><given-names>Jian</given-names></name>
<xref ref-type="aff" rid="aff1-0883911513484205">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Kawazoe</surname><given-names>Naoki</given-names></name>
<xref ref-type="aff" rid="aff3-0883911513484205">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zhang</surname><given-names>Chi</given-names></name>
<xref ref-type="aff" rid="aff1-0883911513484205">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Chen</surname><given-names>Guoping</given-names></name>
<xref ref-type="aff" rid="aff3-0883911513484205">3</xref>
</contrib>
</contrib-group>
<aff id="aff1-0883911513484205"><label>1</label>Department of Orthopaedic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China</aff>
<aff id="aff2-0883911513484205"><label>2</label>Biomedical Research Center, Zhongshan Hospital, Fudan University, Shanghai, China</aff>
<aff id="aff3-0883911513484205"><label>3</label>Tissue Regeneration Materials Unit, International Center for Materials Nanoarchitectonics, National Institute for Materials Science, Tsukuba, Ibaraki, Japan</aff>
<author-notes>
<corresp id="corresp1-0883911513484205">Chi Zhang, Department of Orthopaedic Surgery, Zhongshan Hospital, Fudan University, 136 Yixueyuan Road, Shanghai 200032, China. Email: <email>zhang.chi@zs-hospital.sh.cn</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2013</year>
</pub-date>
<volume>28</volume>
<issue>3</issue>
<fpage>247</fpage>
<lpage>257</lpage>
<permissions>
<copyright-statement>© The Author(s) 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>It is of critical importance to prepare three-dimensional biodegradable porous scaffolds for cartilage tissue engineering. We developed a poly(lactic-<italic>co</italic>-glycolic acid)/collagen hybrid scaffold, which combined the advantages of natural type I collagen and synthetic polymer polylactin 910 knitted mesh (90:10 copolymer of glycolic acid and lactic acid), and a method using this poly(lactic-<italic>co</italic>-glycolic acid)/collagen scaffold to regenerate cartilage with controllable shape. The mechanically strong poly(lactic-<italic>co</italic>-glycolic acid) mesh served as a mechanical skeleton supporting the scaffold, and the collagen benefited cell seeding, distribution, and tissue formation. Bovine chondrocytes were cultured in the hybrid scaffold and transplanted into the subcutaneous sites of nude mice for 4 weeks. All the samples showed spatially uniform cell distribution, natural chondrocyte morphology, and deposition of abundant cartilaginous extracellular matrices such as type II collagen and aggrecan. Production of glycosaminoglycans per DNA reached 74.63% of the natural articular cartilage. The mechanical strength was 62.76% and 71.43% in Young’s modulus and stiffness, respectively, compared to the native articular cartilage. All the samples successfully maintained the original shapes. Our method provides a new strategy for regeneration of cartilage tissue with designed shapes.</p>
</abstract>
<kwd-group>
<kwd>Articular cartilage</kwd>
<kwd>hybrid mesh</kwd>
<kwd>collagen</kwd>
<kwd>three-dimensional biodegradable scaffold</kwd>
<kwd>tissue engineering</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0883911513484205" sec-type="intro">
<title>Introduction</title>
<p>Articular cartilage is an avascular tissue that consists of sparsely embedded chondrocytes in an organic matrix.<sup><xref ref-type="bibr" rid="bibr1-0883911513484205">1</xref>,<xref ref-type="bibr" rid="bibr2-0883911513484205">2</xref></sup> Once damaged due to degenerative or traumatic causes, articular cartilage has poor intrinsic repair capability. Even minor lesions of the cartilage may lead to progressive damage and joint degeneration,<sup><xref ref-type="bibr" rid="bibr3-0883911513484205">3</xref><xref ref-type="bibr" rid="bibr4-0883911513484205"/><xref ref-type="bibr" rid="bibr5-0883911513484205"/><xref ref-type="bibr" rid="bibr6-0883911513484205"/><xref ref-type="bibr" rid="bibr7-0883911513484205"/>–<xref ref-type="bibr" rid="bibr8-0883911513484205">8</xref></sup> which poses a serious clinical problem.</p>
<p>Tissue engineering is one of the most promising alternative therapies for articular cartilage defects.<sup><xref ref-type="bibr" rid="bibr9-0883911513484205">9</xref><xref ref-type="bibr" rid="bibr10-0883911513484205"/>–<xref ref-type="bibr" rid="bibr11-0883911513484205">11</xref></sup> In this strategy, a biodegradable three-dimensional (3D) porous scaffold is necessary to accommodate the transplanted cells as a supportive matrix and to guide new tissue formation. The ideal scaffold for cartilage regeneration should provide sufficient mechanical strength as an initial architecture support to define the ultimate shape of new tissue. At the same time, the biomaterials should be of good cell affinity that facilitates cell attachment, proliferation, and chondrocytes’ function.</p>
<p>Human articular cartilage thickness varies from about 0.5 to 7.1 mm,<sup><xref ref-type="bibr" rid="bibr12-0883911513484205">12</xref>,<xref ref-type="bibr" rid="bibr13-0883911513484205">13</xref></sup> and the defects are usually irregular in three dimensions. This requires the scaffolds for cartilage regeneration to be of adjustable thickness and shape to simulate the real cartilage defect. Various scaffolds have been prepared from naturally derived materials and biodegradable synthetic polymers for the tissue engineering of cartilage. Naturally derived polymers such as collagen and hyaluronic acid are hydrophilic and have specific cell interaction peptides on their surfaces, which are excellent for cell growth, but their mechanical strength is too weak to withstand the biomechanical environment when implanted into the cartilage defect.<sup><xref ref-type="bibr" rid="bibr14-0883911513484205">14</xref><xref ref-type="bibr" rid="bibr15-0883911513484205"/><xref ref-type="bibr" rid="bibr16-0883911513484205"/><xref ref-type="bibr" rid="bibr17-0883911513484205"/><xref ref-type="bibr" rid="bibr18-0883911513484205"/>–<xref ref-type="bibr" rid="bibr19-0883911513484205">19</xref></sup> Synthetic polymers such as poly(lactic acid) (PLA), poly(glycolic acid) (PGA), and their copolymer poly(lactic-<italic>co</italic>-glycolic acid) (PLGA) can be easily formed into designed shapes with high mechanical strength, but their hydrophobic surfaces are not beneficial for cell seeding and proliferation.<sup><xref ref-type="bibr" rid="bibr20-0883911513484205">20</xref><xref ref-type="bibr" rid="bibr21-0883911513484205"/><xref ref-type="bibr" rid="bibr22-0883911513484205"/><xref ref-type="bibr" rid="bibr23-0883911513484205"/>–<xref ref-type="bibr" rid="bibr24-0883911513484205">24</xref></sup></p>
<p>In our previous studies, we developed a biodegradable hybrid scaffold by building type I collagen microsponges with a porous synthetic PLGA knitted mesh skeleton. This scaffold exhibited high mechanical strength, easy handling, efficient cell seeding, and uniform distribution and facilitated the formation of cartilage tissue in in vivo experiments.<sup><xref ref-type="bibr" rid="bibr25-0883911513484205">25</xref>,<xref ref-type="bibr" rid="bibr26-0883911513484205">26</xref></sup> In the present study, we modified our methods, preserving the advantage of this collagen/PLGA hybrid scaffold and used them to build hyaline cartilage with controllable shapes. The biological and biomechanical properties of the new regenerated cartilage were investigated.</p>
</sec>
<sec id="section2-0883911513484205" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="section3-0883911513484205">
<title>Scaffolds’ fabrication</title>
<p>The scaffold is prepared by forming collagen microsponges on the PLGA knitted mesh. The method was modified on the basis of what had been previously reported.<sup><xref ref-type="bibr" rid="bibr25-0883911513484205">25</xref></sup> Briefly, a Vicryl knitted mesh (polylactin 910, Ethicon, Inc., Somerville, NJ) was immersed in a porcine type I collagen acidic solution (pH 3.0, 0.5 wt%) (Koken Co., Ltd, Tokyo, Japan) and placed on a flat copper plate. Then a silicone frame (thickness 2.0 mm, width 6.0 cm, and length 8 cm) was placed onto the knitted PLGA mesh, and 10 mL collagen solution was poured into the frame, and excess collagen solution was removed with a clean glass plate. The scaffold preparations were done in a low-temperature chamber (WT-201, ESPEC, Japan) at −6°C. After 1 h, the frozen PLGA/collagen composites were detached and stored in a −80°C refrigerator for 4 h.</p>
<p>The composites were then freeze dried under a vacuum of 0.2 Torr at 20°C for 24 h (VirTis, SP Industries) to form collagen microsponges, which were further crosslinked by glutaraldehyde vapor at 37°C for 4 h. The crosslinked scaffolds were treated with 0.1 M glycine aqueous solution and washed thoroughly with deionized water before a second freeze dry. For cell culture, the scaffolds were sterilized with ethylene oxide gas and ventilated in a ventilation chamber for over 24 h.</p>
</sec>
<sec id="section4-0883911513484205">
<title>Scanning electron microscope observation</title>
<p>The scaffolds were observed by a scanning electron microscope (SEM) (JSM-6400Fs; JEOL, Tokyo, Japan) for PLGA/collagen hybrid microscopic structures. The top, bottom surfaces and cross-section were coated with platinum in a sputter coater (Sanyu Denshi, Tokyo, Japan) (50 mTorr, 5 mA, 180 s). SEM was also used to view the cell distribution of bovine articular chondrocytes (BACs) on the scaffolds; the BACs/scaffold composites were harvested after 24-h culture, washed in MilliQ water (5 min, ×3), phosphate-buffered saline (PBS, 5 min, ×3), and fixed with 0.5% glutaraldehyde PBS solution at room temperature for 1 h. The samples were frozen at −30°C, sectioned, and freeze dried before being coated and viewed by SEM.</p>
</sec>
<sec id="section5-0883911513484205">
<title>In vitro bovine chondrocytes culture and implantation</title>
<p>Bovine chondrocytes were isolated from articular cartilage from the knees of a 4-week-old calf and digested with 0.2% collagenase type II (Worthington Biochemical Co., Lakewood, NJ), as described previously.<sup><xref ref-type="bibr" rid="bibr25-0883911513484205">25</xref></sup> The cells were subcultured in culture medium (Dulbecco’s modified Eagle medium (DMEM) containing 10% fetal bovine serum (FBS), 4500 mg/L glucose, 584 mg/L glutamine, 100 U/mL penicillin, 100 µg/mL streptomycin, 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 0.1 mM nonessential amino acids, 0.4 mM proline, and 50 mg/L ascorbic acid) under an atmosphere of 5% CO<sub>2</sub> at 37°C. After being subcultured once, the chondrocytes were collected and suspended in a culture medium at a density of 3×10<sup>7</sup> cells/mL.</p>
<p>The chondrocyte suspension was dropped onto the collagen sponge sides of scaffolds in 100-mm culture dishes. Glass rings were used to enhance cell seeding efficiency. The unattached cells were collected and counted after 3-h culture. The seeding efficiency was calculated by dividing the adhered cell number by seeded cell number. After culturing in vitro for 3 days, the BACs/scaffold composites were laminated into three-layer sheets and trimmed into designed shapes such as star, heart, half-moon, and rectangle (<xref ref-type="fig" rid="fig1-0883911513484205">Figure 1</xref>). The trimmed laminates continued to be cultured for another 4 days before being subcutaneously transplanted into the dorsum of nude mice. After 4 weeks of in vivo implantation, the mice were sacrificed and the composites were harvested. The animal experiment was conducted according to the committee guidelines for animal experiments of Zhongshan Hospital, Fudan University.</p>
<fig id="fig1-0883911513484205" position="float">
<label>Figure 1.</label>
<caption>
<p>Schematic illustration of PLGA/collagen hybrid scaffold thickness and shape designs.</p>
<p>PLGA: poly(lactic-<italic>co</italic>-glycolic acid).</p>
<p>Black: PLGA knitted mesh; gray: type I collagen sponge.</p>
</caption>
<graphic xlink:href="10.1177_0883911513484205-fig1.tif"/>
</fig>
</sec>
<sec id="section6-0883911513484205">
<title>Histological and immunohistological staining</title>
<p>Harvested samples were fixed in phosphate-buffered 10% formalin, dehydrated in ethanol, cleared in lemonsol, and embedded in paraffin. They were sectioned at a thickness of 8 µm and stained with hematoxylin/eosin, safranin O/fast green, and toluidine blue.</p>
<p>The type I collagen, type II collagen, and cartilage proteoglycan were immunohistologically stained using mouse antibovine type I collagen antibody (Abcam Co., Cambridge, MA), rabbit antibovine type II collagen monoclonal antibody (Millipore Co., Billerica, MA), and mouse antibovine cartilage proteoglycan monoclonal antibody (Abcam Co., Cambridge, MA), which recognize the short peptides substituted with keratin sulfate side chains and within the core protein of proteoglycans in articular cartilage (Abcam Co., Cambridge, MA) and a Dako LSAB Kit, Peroxidase (Dako Inc., Carpinteria, CA) according to the instructions accompanying the kit. Briefly, the deparaffinized sections were incubated with proteinase K enzyme in Tris-buffered saline (TBS, 1:50 working dilution, pH 7.4) at room temperature (RT) for 5 min and blocked with peroxidase blocking solution for 10 min and 10% goat serum solution for 30 min. The sections were then incubated with anti-type I collagen (1:200 working dilution), anti-type II collagen (1:150 working dilution), and anti-proteoglycan antibodies (1:150 working dilution) for 30 min. The biotinylated secondary antibody (antirabbit or mouse immunoglobulins) was applied for 30 min followed by incubation with horseradish peroxide-conjugated streptavidin for 10 min. The sections were incubated with 3-amino-9-ethylcarbazole as the color substrate for 10 min to visualize the bound antibodies. All incubations were at RT.</p>
</sec>
<sec id="section7-0883911513484205">
<title>Biochemical analysis</title>
<p>The BACs/scaffold composites that were transplanted in the subcutaneous site of nude mice for 4 weeks were harvested for biochemical analysis of DNA and sulfated glycosaminoglycans (GAGs). The samples were washed with PBS, freeze dried at −80°C, and digested with 1.0 mL of papain (Sigma-Aldrich, St. Louis, MO). The amount of DNA in the papain digests was measured after staining with fluorescent dye, Hoechst 33258 (Sigma-Aldrich, St. Louis, MO), using a spectrofluorometer (JASCO, Tokyo, Japan). The sulfated GAG content was determined using a sulfated GAG assay kit, BlyscanTM (Biocolor Ltd, Newtownabbey, Northern Ireland) and an ultraviolet–visible spectrophotometer (JASCO, Tokyo, Japan) at 656 nm. The GAG results were normalized by the amount of DNA and reported as microgram GAGs per microgram DNA. Six samples were used to calculate the mean and standard deviation. The natural cartilage harvested from the bovine knee was used as the control. The data were expressed as the average and standard deviation.</p>
</sec>
<sec id="section8-0883911513484205">
<title>Mechanical tests</title>
<p>The BACs/mesh composites transplanted in the subcutaneous sites of nude mice were harvested and measured using a static tensile test machine (TMI UTM-10T; Toyo Baldwin Co., Ltd, Tokyo, Japan). The samples were trimmed into cylinder discs with a biopsy punch (Kai medical, Gifu, Japan) with 6-mm diameters before testing. The temperature during testing was 25°C. A static load of 1.0 N and a compression rate of 0.5 mm/min were used for all mechanical tests. The ultimate Young’s modulus and stiffness were calculated using the following two equations. The average values were calculated from six measurements.</p>
<p><disp-formula id="disp-formula1-0883911513484205">
<mml:math display="block" id="math1-0883911513484205">
<mml:mrow>
<mml:mi>E</mml:mi>
<mml:mo>=</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>F</mml:mi>
<mml:mo>/</mml:mo>
<mml:msub>
<mml:mi>A</mml:mi>
<mml:mn>0</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>/</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>Δ</mml:mi>
<mml:mi>L</mml:mi>
<mml:mo>/</mml:mo>
<mml:msub>
<mml:mi>L</mml:mi>
<mml:mn>0</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula1-0883911513484205" xlink:href="10.1177_0883911513484205-eq1.tif"/></disp-formula></p>
<p><disp-formula id="disp-formula2-0883911513484205">
<mml:math display="block" id="math2-0883911513484205">
<mml:mrow>
<mml:mi>S</mml:mi>
<mml:mo>=</mml:mo>
<mml:mi>F</mml:mi>
<mml:mo>/</mml:mo>
<mml:mi>Δ</mml:mi>
<mml:mi>L</mml:mi>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula2-0883911513484205" xlink:href="10.1177_0883911513484205-eq2.tif"/></disp-formula></p>
<p><italic>E</italic> is the Young’s modulus (modulus of elasticity, MPa); <italic>S</italic> is the stiffness (N/mm); <italic>F</italic> is the force applied to the object; <italic>A<sub>0</sub></italic> is the original cross-sectional area through which the force is applied; <italic>ΔL</italic> is the amount by which the length of the object changes; and <italic>L<sub>0</sub></italic> is the original length of the object.</p>
</sec>
<sec id="section9-0883911513484205">
<title>Statistics analysis</title>
<p>All quantitative data were analyzed with Origin 8.5 software (OriginLab Corporation) and expressed as the mean ± standard deviation. Statistical comparisons were carried out using analysis of variance (ANOVA, Origin 8.5). A value of <italic>p</italic> &lt; 0.05 was considered to be statistically significant.</p>
</sec>
</sec>
<sec id="section10-0883911513484205" sec-type="results">
<title>Results</title>
<sec id="section11-0883911513484205">
<title>Characterization of PLGA/collagen hybrid meshes</title>
<p>Synthetic PLGA and collagen hybridization was achieved by forming collagen microsponges in the openings of the PLGA knitted mesh. The SEM images of the microstructure are shown in <xref ref-type="fig" rid="fig2-0883911513484205">Figure 2(a)</xref> to <xref ref-type="fig" rid="fig2-0883911513484205">(c)</xref>.</p>
<fig id="fig2-0883911513484205" position="float">
<label>Figure 2.</label>
<caption>
<p>SEM images of PLGA/collagen hybrid scaffolds before and after BACs seeding. (a–c) SEM observation of scaffolds before BACs seeding. (a) Top view, (b) bottom view, and (c) cross-section view. (d–f) SEM observation of scaffolds after BACs seeding. (d) Top view, (e) bottom view, and (f) cross-section view. Size bars are indicated in the figures.</p>
</caption>
<graphic xlink:href="10.1177_0883911513484205-fig2.tif"/>
</fig>
<p>From the surface view of the scaffolds, open pores were observed on top of the collagen layer with most of the pore sizes over 120 µm. Porous interconnected structures can be seen at the surface and cross-section views. From the bottom view, web-like collagen microsponges were seen in the openings of the knitted mesh, which were connected by the collagen fibers that lay on the PLGA fiber bundles.</p>
<p>The distributions of cells on the scaffolds were further demonstrated in <xref ref-type="fig" rid="fig2-0883911513484205">Figure 2(d)–(f)</xref>. After 24-h culture, chondrocytes spread along the porous collagen sponge and PLGA fibers and secreted extracellular matrix. Abundant cells were observed covering the open pores of the scaffold surface (<xref ref-type="fig" rid="fig2-0883911513484205">Figure 2(d)</xref>). Cells could be seen penetrating from the seeding side to the bottom side. Excreted extracellular matrix materials (ECMs) were homogenously distributed in the hybrid meshes forming a membrane-like tissue and closed the pores of the scaffold (<xref ref-type="fig" rid="fig2-0883911513484205">Figure 2(e)</xref>). In the cross-section view (<xref ref-type="fig" rid="fig2-0883911513484205">Figure 2(f)</xref>), cells could be observed in the center of the scaffolds, attaching to the walls of collagen mesh. By providing more surface area, the porous collagen microsponges in the scaffold enhanced the spatial distribution of the homogeneous cells and ECM. The mean cell seeding efficiency examined at 6 h after seeding was 96.26±3.02%.</p>
</sec>
<sec id="section12-0883911513484205">
<title>Implantation studies</title>
<p>The implants were harvested after 4 weeks. No evidence of superficial inflammatory reaction such as infection or fistula formation was observed in implantation and adjacent sites. The designed shapes of star, heart, half-moon, and rectangle can be easily distinguished.</p>
<p>The implants were easily dissected from the surrounding soft connective tissue. The newly formed cartilage had an ivory white appearance (<xref ref-type="fig" rid="fig3-0883911513484205">Figure 3</xref>). The implants were flexible, strong, and felt-like natural articular cartilage.</p>
<fig id="fig3-0883911513484205" position="float">
<label>Figure 3.</label>
<caption>
<p>Gross view of BACs-PLGA/collagen composite implants after 2, 4, and 8 weeks.</p>
<p>BACs: bovine articular chondrocytes; PLGA: poly(lactic-<italic>co</italic>-glycolic acid).</p>
</caption>
<graphic xlink:href="10.1177_0883911513484205-fig3.tif"/>
</fig>
</sec>
<sec id="section13-0883911513484205">
<title>Biochemical analysis</title>
<p>The DNA and sulfated GAG contents in the samples were analyzed by staining with Hoechst 33258 dye, and using the Blyscan<sup>™</sup> GAG assay natural cartilage from a bovine knee joint was used as a control. The GAG content per microgram DNA reached 92.36±7.55 µg at 4 weeks, which is about 74.63% when compared with that of natural cartilage (<xref ref-type="fig" rid="fig4-0883911513484205">Figure 4</xref>).</p>
<fig id="fig4-0883911513484205" position="float">
<label>Figure 4.</label>
<caption>
<p>Microgram GAG per microgram DNA of BACs-PLGA/collagen composite after 4 weeks of implantation.</p>
<p>GAG: glycosaminoglycans; BACs: bovine articular chondrocytes; PLGA: poly(lactic-<italic>co</italic>-glycolic acid).</p>
<p>*<italic>p</italic> &lt; 0.05.</p>
</caption>
<graphic xlink:href="10.1177_0883911513484205-fig4.tif"/>
</fig>
</sec>
<sec id="section14-0883911513484205">
<title>Histological and immunohistological staining</title>
<p>The histological and immunohistological staining of the implants are shown in <xref ref-type="fig" rid="fig5-0883911513484205">Figure 5</xref>. Hematoxylin and eosin staining indicated that the chondrocytes in all the implants were viable, proliferating, and secreting extracellular matrix components to form homogeneously compact cartilage tissues. A uniform spatial cell distribution throughout all the implants both radically and longitudinally was achieved at 4 weeks (<xref ref-type="fig" rid="fig5-0883911513484205">Figure 5(a)</xref>). The chondrocytes showed their natural round morphology during viewing at a higher magnification. The bright safranin O-positive staining indicated abundant GAGs homogeneously distributed throughout the implants (<xref ref-type="fig" rid="fig5-0883911513484205">Figure 5(b)</xref>). Toluidine blue staining demonstrated the typical metachromasia of articular cartilage, coinciding with the results of safranin O staining. (<xref ref-type="fig" rid="fig5-0883911513484205">Figure 5(c)</xref>)</p>
<fig id="fig5-0883911513484205" position="float">
<label>Figure 5.</label>
<caption>
<p>Histological and immunohistological staining of BACs-PLGA/collagen composites after 4 weeks of transplantation. (a) HE, (b) safranin O/fast blue staining, (c) toluidine blue, (d) collagen I immunohistochemical staining, (e) collagen II immunohistochemical staining, and (f) aggrecan immunohistochemical staining. Bar = 200 µm.</p>
<p>BACs: Bovine articular chondrocytes; PLGA: poly(lactic-co-glycolic acid); HE: hematoxylin.</p>
</caption>
<graphic xlink:href="10.1177_0883911513484205-fig5.tif"/>
</fig>
<p>Immunohistological staining showed a strong positive homogeneous extracellular staining for type II collagen and aggrecan (<xref ref-type="fig" rid="fig5-0883911513484205">Figure 5(e)</xref> and <xref ref-type="fig" rid="fig5-0883911513484205">(f)</xref>) but a weak staining for type I collagen (<xref ref-type="fig" rid="fig5-0883911513484205">Figure 5(d)</xref>). This is evidence that during the in vivo implantation, more new articular cartilage matrix was regenerated, while the collagen sponge was gradually degraded and substituted.</p>
<p>At 4 weeks, the knitted polymer web was still histologically detectable within the tissue-engineered specimens, but the PLGA fibers were swollen, which indicated its degradation.</p>
</sec>
<sec id="section15-0883911513484205">
<title>Mechanical properties</title>
<p>The mechanical properties of the implants after 4 weeks and bovine native articular cartilage were evaluated using a static mechanical spectrometer. The Young’s modulus and stiffness are shown in <xref ref-type="table" rid="table1-0883911513484205">Table 1</xref>. The Young’s modulus and stiffness of the implants reached 62.76% and 71.43%, respectively of the native bovine cartilage samples.</p>
<table-wrap id="table1-0883911513484205" position="float">
<label>Table 1.</label>
<caption>
<p>Biomechanical properties of tissue-engineered cartilage and bovine native articular cartilage.</p>
</caption>
<graphic alternate-form-of="table1-0883911513484205" xlink:href="10.1177_0883911513484205-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Samples</th>
<th align="left">Young’s modulus (<italic>E</italic>, MPa)</th>
<th align="left">Stiffness (N/mm)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Native cartilage</td>
<td>26.70 ± 3.95</td>
<td>80.25 ± 6.98</td>
</tr>
<tr>
<td>Engineered cartilage</td>
<td>18.73 ± 2.36 <sup><xref ref-type="table-fn" rid="table-fn2-0883911513484205">*</xref></sup></td>
<td>64.52 ± 4.09<xref ref-type="table-fn" rid="table-fn2-0883911513484205">**</xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0883911513484205">
<p>Shown as mean ± SD, <italic>n</italic> = 6.</p>
</fn>
<fn id="table-fn2-0883911513484205">
<label>**</label>
<p><italic>p</italic> &lt; 0.05.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="section16-0883911513484205" sec-type="discussion">
<title>Discussion</title>
<p>The typical strategy of tissue engineering includes either the delivery of expanded cell populations within the tissue engineering construct or the recruitment of host cells local to the site of damage through the use of conductive scaffolds and inductive biological signals.<sup><xref ref-type="bibr" rid="bibr3-0883911513484205">3</xref><xref ref-type="bibr" rid="bibr4-0883911513484205"/><xref ref-type="bibr" rid="bibr5-0883911513484205"/><xref ref-type="bibr" rid="bibr6-0883911513484205"/><xref ref-type="bibr" rid="bibr7-0883911513484205"/><xref ref-type="bibr" rid="bibr8-0883911513484205"/><xref ref-type="bibr" rid="bibr9-0883911513484205"/>–<xref ref-type="bibr" rid="bibr10-0883911513484205">10</xref></sup> Ideal scaffolds should fulfill these requirements by incorporating facile modes of cell delivery while providing the requisite extracellular microenvironment for cell-driven tissue development. For cartilage regeneration and transplantation, it is very important that the scaffolds are tailored into the shape and size to fit into the defects and facilitate a spatially uniform cell distribution throughout the construct.<sup><xref ref-type="bibr" rid="bibr9-0883911513484205">9</xref><xref ref-type="bibr" rid="bibr10-0883911513484205"/>–<xref ref-type="bibr" rid="bibr11-0883911513484205">11</xref></sup> The orthopedic and plastic surgeons’ demand for better and more accessible cartilage grafts for functional and cosmetic purposes is a great challenge to develop new methods to provide excellent biological cartilage substitutes with easy-to-use 3D structures on the operation table.</p>
<p>The scaffolds for cartilage regeneration should span the thickness of native cartilage for future clinical application. Ateshian et al.<sup><xref ref-type="bibr" rid="bibr12-0883911513484205">12</xref></sup> reported that the thickness of human articular cartilage in the tibia plateau varies from 0.35 to 6.25 mm and in the patella from 1.0 to 6.0 mm. Kladny et al.<sup><xref ref-type="bibr" rid="bibr13-0883911513484205">13</xref></sup> measured the thickness of human articular cartilage with magnetic resonance imaging (MRI) and found it varies from 0.5 to 7.1 mm. However, as the thickness of the scaffold increases, it becomes much more difficult to achieve higher cell seeding efficiency and homogeneous cell distribution. Based on the literature, even for scaffolds with porosity higher than 97%, there were still these problems. Freed et al.<sup><xref ref-type="bibr" rid="bibr27-0883911513484205">27</xref></sup> investigated the influence of thickness on chondrogenesis with PGA scaffolds and reported that both GAG content and cell density decreased with increasing thickness. Gugala et al.<sup><xref ref-type="bibr" rid="bibr28-0883911513484205">28</xref></sup> seeded chondrocytes on 2-mm-thick PLA scaffolds, and cultured in vitro under static conditions. After 9 weeks of histological evaluation, they showed that most proteoglycans were present at the seeded side of the scaffold.<sup><xref ref-type="bibr" rid="bibr28-0883911513484205">28</xref></sup> Many methods have been developed to prepare cartilage grafts with designed shapes such as crushing,<sup><xref ref-type="bibr" rid="bibr29-0883911513484205">29</xref>,<xref ref-type="bibr" rid="bibr30-0883911513484205">30</xref></sup> thermoforming,<sup><xref ref-type="bibr" rid="bibr31-0883911513484205">31</xref>,<xref ref-type="bibr" rid="bibr32-0883911513484205">32</xref></sup> and electroforming.<sup><xref ref-type="bibr" rid="bibr33-0883911513484205">33</xref>,<xref ref-type="bibr" rid="bibr34-0883911513484205">34</xref></sup> All these methods result in focal chondrocyte necrosis and ECM denaturation, which decrease the vitality of cartilage graft samples that lead to incidences of high graft failure.</p>
<p>In the present study, a hybrid collagen/PLGA scaffold was assembled and used for cartilage tissue engineering. This scaffold combines the advantages of two biomaterials, PLGA mesh as the skeleton and collagen microsponges to enhance cell adhesion. Our previous work demonstrated that this scaffold is outstanding for the regeneration of tissues such as skin, cartilage, and ligament.<sup><xref ref-type="bibr" rid="bibr25-0883911513484205">25</xref>,<xref ref-type="bibr" rid="bibr26-0883911513484205">26</xref></sup> In this study, high cell seeding efficiency of 96.26% and uniform cell distribution throughout the scaffold resulted from the excellent pore sizes, interconnectivity, and biocompatibility of this scaffold. After 4 weeks of transplantation, new hyaline cartilage-like ECM tissues were formed, and the samples looked ivory white without visible blood vessel infiltration.</p>
<p>We also hope to explore a new strategy for scaffold design in tissue engineering applications. Tissue defects in articular cartilage or skin lesions usually vary in thickness and are irregular in shape. Tissue grafts prepared conveniently at the bench in a short time with predesigned thickness and shape will drive tissue engineering products toward clinical use.<sup><xref ref-type="bibr" rid="bibr35-0883911513484205">35</xref><xref ref-type="bibr" rid="bibr36-0883911513484205"/><xref ref-type="bibr" rid="bibr37-0883911513484205"/>–<xref ref-type="bibr" rid="bibr38-0883911513484205">38</xref></sup> With the hybrid PLGA/collagen scaffold, the thickness of the construct is easily adjusted by laminating the scaffold sheet to a desired thickness. Each collagen sponge layer was seeded homogenously with numerous BACs eliminated the seeding problems plagued by other thick scaffold designs. Our scaffold also retains much tensile strength of the PLGA knitted mesh, which facilitates trimming into designed shapes. After 4 weeks of transplantation, all the samples retained their original shape and diameter. In addition, our method will allow different cell lines to be seeded on different layers, which may be required to regenerate more complicated tissues, such as skin, blood vessel, and trachea.<sup><xref ref-type="bibr" rid="bibr39-0883911513484205">39</xref><xref ref-type="bibr" rid="bibr40-0883911513484205"/>–<xref ref-type="bibr" rid="bibr41-0883911513484205">41</xref></sup></p>
<p>Although our tissue engineering techniques have been quite successful in mimicking hyaline cartilage, artificial cartilage is still generally mechanically inferior to native tissue.<sup><xref ref-type="bibr" rid="bibr3-0883911513484205">3</xref>,<xref ref-type="bibr" rid="bibr7-0883911513484205">7</xref>
<xref ref-type="bibr" rid="bibr8-0883911513484205"/><xref ref-type="bibr" rid="bibr9-0883911513484205"/>–<xref ref-type="bibr" rid="bibr10-0883911513484205">10</xref>,<xref ref-type="bibr" rid="bibr35-0883911513484205">35</xref>,<xref ref-type="bibr" rid="bibr36-0883911513484205">36</xref></sup> Tissue-engineered cartilage substitutes should have sufficient biomechanical strength while morphologically and biochemically simulating native cartilage. In the present study, the Young’s modulus and stiffness, were increased in four weeks to 70.2% and 80.4%, respectively, compared to natural cartilage. This is significantly better than other cartilage regeneration approaches. The abundant proteoglycan shown in the stainings accounted for the high compressive mechanical properties of the engineered cartilage.<sup><xref ref-type="bibr" rid="bibr42-0883911513484205">42</xref><xref ref-type="bibr" rid="bibr43-0883911513484205"/><xref ref-type="bibr" rid="bibr44-0883911513484205"/>–<xref ref-type="bibr" rid="bibr45-0883911513484205">45</xref></sup> The mechanical and material environments are particularly important for the biochemical and architectural development of chondrogenesis in vivo.<sup><xref ref-type="bibr" rid="bibr42-0883911513484205">42</xref>,<xref ref-type="bibr" rid="bibr43-0883911513484205">43</xref></sup> Even minor changes in the composition and structure of engineered articular cartilage will lead to significant changes in mechanical properties,<sup><xref ref-type="bibr" rid="bibr44-0883911513484205">44</xref></sup> which explains why the mechanical characteristics of the cartilage engineered in our subcutaneous model did not match those of native bovine articular cartilage. This warrants further research using novel techniques such as bioreactors to mimic the human knee environment for cartilage tissue engineering and to improve the chemical constitution and the mechanical properties of engineered articular cartilage.<sup><xref ref-type="bibr" rid="bibr46-0883911513484205">46</xref>,<xref ref-type="bibr" rid="bibr47-0883911513484205">47</xref></sup></p>
</sec>
<sec id="section17-0883911513484205" sec-type="conclusions">
<title>Conclusion</title>
<p>The PLGA/collagen hybrid scaffolds benefited cell seeding and hyaline cartilage-like tissue formation. Our method of preparing artificial cartilage with designed thickness and shape provided a new strategy for future tissue engineering.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<label>Declaration of conflicting interests</label>
<p>The authors declare that there are no conflicts of interest.</p>
</fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This work was supported by the National Natural Science Foundation of China (Grant No. 81101351).</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0883911513484205">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Getgood</surname><given-names>A</given-names></name>
<name><surname>Brooks</surname><given-names>R</given-names></name>
<name><surname>Fortier</surname><given-names>L</given-names></name><etal/>
</person-group>. <article-title>Articular cartilage tissue engineering: today’s research, tomorrow’s practice?</article-title> <source>J Bone Joint Surg Br</source> <year>2009</year>; <volume>91</volume>: <fpage>565</fpage>–<lpage>576</lpage>.</citation>
</ref>
<ref id="bibr2-0883911513484205">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Magne</surname><given-names>D</given-names></name>
<name><surname>Julien</surname><given-names>M</given-names></name>
<name><surname>Vinatier</surname><given-names>C</given-names></name><etal/>
</person-group>. <article-title>Cartilage formation in growth plate and arteries: from physiology to pathology</article-title>. <source>Bioessays</source> <year>2005</year>; <volume>27</volume>: <fpage>708</fpage>–<lpage>716</lpage>.</citation>
</ref>
<ref id="bibr3-0883911513484205">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chiang</surname><given-names>H</given-names></name>
<name><surname>Jiang</surname><given-names>CC</given-names></name>
</person-group>. <article-title>Repair of articular cartilage defects: review and perspectives</article-title>. <source>J Formos Med Assoc</source> <year>2009</year>; <volume>108</volume>: <fpage>87</fpage>–<lpage>101</lpage>.</citation>
</ref>
<ref id="bibr4-0883911513484205">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname><given-names>H</given-names></name>
<name><surname>Zheng</surname><given-names>Q</given-names></name>
<name><surname>Xiao</surname><given-names>Y</given-names></name><etal/>
</person-group>. <article-title>Rat cartilage repair using nanophase PLGA/HA composite and mesenchymal stem cells</article-title>. <source>J Bioact Compat Polym</source> <year>2009</year>; <volume>24</volume>: <fpage>83</fpage>–<lpage>99</lpage>.</citation>
</ref>
<ref id="bibr5-0883911513484205">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hangody</surname><given-names>L</given-names></name>
<name><surname>Füles</surname><given-names>P</given-names></name>
</person-group>. <article-title>Autologous osteochondral mosaicplasty for the treatment of full-thickness defects of weight-bearing joints: ten years of experimental and clinical experience</article-title>. <source>J Bone Joint Surg Am</source> <year>2003</year>; <volume>85</volume>: <fpage>25</fpage>–<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr6-0883911513484205">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Widuchowski</surname><given-names>W</given-names></name>
<name><surname>Widuchowski</surname><given-names>J</given-names></name>
<name><surname>Koczy</surname><given-names>B</given-names></name><etal/>
</person-group>. <article-title>Untreated asymptomatic deep cartilage lesions associated with anterior cruciate ligament injury: results at 10- and 15-year follow-up</article-title>. <source>Am J Sports Med</source> <year>2009</year>; <volume>37</volume>: <fpage>688</fpage>–<lpage>692</lpage>.</citation>
</ref>
<ref id="bibr7-0883911513484205">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Magnussen</surname><given-names>RA</given-names></name>
<name><surname>Dunn</surname><given-names>WR</given-names></name>
<name><surname>Carey</surname><given-names>JL</given-names></name><etal/>
</person-group>. <article-title>Treatment of focal articular cartilage defects in the knee: a systematic review</article-title>. <source>Clin Orthop Relat Res</source> <year>2008</year>; <volume>466</volume>: <fpage>952</fpage>–<lpage>962</lpage>.</citation>
</ref>
<ref id="bibr8-0883911513484205">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bhosale</surname><given-names>M</given-names></name>
<name><surname>Richardson</surname><given-names>JB</given-names></name>
</person-group>. <article-title>Articular cartilage: structure, injuries and review of management</article-title>. <source>Br Med Bull</source> <year>2008</year>; <volume>87</volume>: <fpage>77</fpage>–<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr9-0883911513484205">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Iwasa</surname><given-names>J</given-names></name>
<name><surname>Engebretsen</surname><given-names>L</given-names></name>
<name><surname>Shima</surname><given-names>Y</given-names></name><etal/>
</person-group>. <article-title>Clinical application of scaffolds for cartilage tissue engineering</article-title>. <source>Knee Surg Sports Traumatol Arthrosc</source> <year>2009</year>; <volume>17</volume>: <fpage>561</fpage>–<lpage>577</lpage>.</citation>
</ref>
<ref id="bibr10-0883911513484205">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kock</surname><given-names>L</given-names></name>
<name><surname>van Donkelaar</surname><given-names>CC</given-names></name>
<name><surname>Ito</surname><given-names>K</given-names></name>
</person-group>. <article-title>Tissue engineering of functional articular cartilage: the current status</article-title>. <source>Cell Tissue Res</source> <year>2012</year>; <volume>347</volume>: <fpage>613</fpage>–<lpage>627</lpage>.</citation>
</ref>
<ref id="bibr11-0883911513484205">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sherwood</surname><given-names>JK</given-names></name>
<name><surname>Riley</surname><given-names>SL</given-names></name>
<name><surname>Palazzolo</surname><given-names>R</given-names></name><etal/>
</person-group>. <article-title>A three dimensional osteochondral composite scaffold for articular cartilage repair</article-title>. <source>Biomaterials</source> <year>2002</year>; <volume>23</volume>: <fpage>4739</fpage>–<lpage>4751</lpage>.</citation>
</ref>
<ref id="bibr12-0883911513484205">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ateshian</surname><given-names>GA</given-names></name>
<name><surname>Soslowsky</surname><given-names>LJ</given-names></name>
<name><surname>Mow</surname><given-names>VC</given-names></name>
</person-group>. <article-title>Quantitation of articular surface topography and cartilage thickness in knee joints using stereophotogrammetry</article-title>. <source>J Biomech</source> <year>1991</year>; <volume>24</volume>: <fpage>761</fpage>–<lpage>776</lpage>.</citation>
</ref>
<ref id="bibr13-0883911513484205">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kladny</surname><given-names>B</given-names></name>
<name><surname>Martus</surname><given-names>P</given-names></name>
<name><surname>Schiwy-Bochat</surname><given-names>KH</given-names></name><etal/>
</person-group>. <article-title>Measurement of cartilage thickness in the human knee-joint by magnetic resonance imaging using a three-dimensional gradient- echo sequence</article-title>. <source>Int Orthop</source> <year>1999</year>; <volume>23</volume>: <fpage>264</fpage>–<lpage>267</lpage>.</citation>
</ref>
<ref id="bibr14-0883911513484205">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nöth</surname><given-names>U</given-names></name>
<name><surname>Rackwitz</surname><given-names>L</given-names></name>
<name><surname>Heymer</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Chondrogenic differentiation of human mesenchymal stem cells in collagen type I hydrogels</article-title>. <source>J Biomed Mater Res A</source> <year>2007</year>; <volume>83</volume>: <fpage>626</fpage>–<lpage>635</lpage>.</citation>
</ref>
<ref id="bibr15-0883911513484205">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Glowacki</surname><given-names>J</given-names></name>
<name><surname>Mizuno</surname><given-names>S</given-names></name>
</person-group>. <article-title>Collagen scaffolds for tissue engineering</article-title>. <source>Biopolymers</source> <year>2008</year>; <volume>89</volume>: <fpage>338</fpage>–<lpage>344</lpage>.</citation>
</ref>
<ref id="bibr16-0883911513484205">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gotterbarm</surname><given-names>T</given-names></name>
<name><surname>Richter</surname><given-names>W</given-names></name>
<name><surname>Jung</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>An in vivo study of a growth-factor enhanced, cell free, two-layered collagen-tricalcium phosphate in deep osteochondral defects</article-title>. <source>Biomaterials</source> <year>2006</year>; <volume>27</volume>: <fpage>3387</fpage>–<lpage>3395</lpage>.</citation>
</ref>
<ref id="bibr17-0883911513484205">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lin</surname><given-names>Y</given-names></name>
<name><surname>Matsumoto</surname><given-names>Y</given-names></name>
<name><surname>Kuroyanagi</surname><given-names>Y</given-names></name><etal/>
</person-group>. <article-title>A bilayer hyaluronic acid wound dressing to promote wound healing in diabetic ulcer</article-title>. <source>J Bioact Compat Polym</source> <year>2009</year>; <volume>24</volume>: <fpage>424</fpage>–<lpage>443</lpage>.</citation>
</ref>
<ref id="bibr18-0883911513484205">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liao</surname><given-names>E</given-names></name>
<name><surname>Yaszemski</surname><given-names>M</given-names></name>
<name><surname>Krebsbach</surname><given-names>P</given-names></name><etal/>
</person-group>. <article-title>Tissue-engineered cartilage constructs using composite hyaluronic acid/collagen hydrogels and designed poly(propylene fumarate) scaffolds</article-title>. <source>Tissue Eng</source> <year>2007</year>; <volume>13</volume>: <fpage>537</fpage>–<lpage>550</lpage>.</citation>
</ref>
<ref id="bibr19-0883911513484205">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ko</surname><given-names>Y</given-names></name>
<name><surname>Kawazoe</surname><given-names>N</given-names></name>
<name><surname>Tateishi</surname><given-names>T</given-names></name><etal/>
</person-group>. <article-title>Preparation of novel collagen sponges using an ice particulate template</article-title>. <source>J Bioact Compat Polym</source> <year>2010</year>; <volume>25</volume>: <fpage>360</fpage>–<lpage>373</lpage>.</citation>
</ref>
<ref id="bibr20-0883911513484205">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>MS</given-names></name>
<name><surname>Ahn</surname><given-names>HH</given-names></name>
<name><surname>Shin</surname><given-names>YN</given-names></name><etal/>
</person-group>. <article-title>An in vivo study of the host tissue response to subcutaneous implantation of PLGA- and/or porcine small intestinal submucosa-based scaffolds</article-title>. <source>Biomaterials</source> <year>2007</year>; <volume>28</volume>(<issue>34</issue>): <fpage>5137</fpage>–<lpage>5143</lpage>.</citation>
</ref>
<ref id="bibr21-0883911513484205">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Choi</surname><given-names>YS</given-names></name>
<name><surname>Park</surname><given-names>SN</given-names></name>
<name><surname>Suh</surname><given-names>H</given-names></name>
</person-group>. <article-title>Adipose tissue engineering using mesenchymal stem cells attached to injectable PLGA spheres</article-title>. <source>Biomaterials</source> <year>2005</year>; <volume>26</volume>: <fpage>5855</fpage>–<lpage>5863</lpage>.</citation>
</ref>
<ref id="bibr22-0883911513484205">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kawazoe</surname><given-names>N</given-names></name>
<name><surname>Lin</surname><given-names>X</given-names></name>
<name><surname>Tateishi</surname><given-names>T</given-names></name><etal/>
</person-group>. <article-title>Three-dimensional cultures of rat pancreatic RIN-5F cells in porous PLGA-collagen hybrid scaffolds</article-title>. <source>J Bioact Compat Polym</source> <year>2009</year>; <volume>24</volume>: <fpage>25</fpage>–<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr23-0883911513484205">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Baek</surname><given-names>CH</given-names></name>
<name><surname>Ko</surname><given-names>YJ</given-names></name>
</person-group>. <article-title>Characteristics of tissue-engineered cartilage on macroporous biodegradable PLGA scaffold</article-title>. <source>Laryngoscope</source> <year>2006</year>; <volume>116</volume>: <fpage>1829</fpage>–<lpage>1834</lpage>.</citation>
</ref>
<ref id="bibr24-0883911513484205">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Uematsu</surname><given-names>K</given-names></name>
<name><surname>Hattori</surname><given-names>K</given-names></name>
<name><surname>Ishimoto</surname><given-names>Y</given-names></name><etal/>
</person-group>. <article-title>Cartilage regeneration using mesenchymal stem cells and a three-dimensional poly-lactic-glycolic acid (PLGA) scaffold</article-title>. <source>Biomaterials</source> <year>2005</year>; <volume>26</volume>: <fpage>4273</fpage>–<lpage>4279</lpage>.</citation>
</ref>
<ref id="bibr25-0883911513484205">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dai</surname><given-names>W</given-names></name>
<name><surname>Kawazoe</surname><given-names>N</given-names></name>
<name><surname>Lin</surname><given-names>X</given-names></name><etal/>
</person-group>. <article-title>The influence of structural design of PLGA/collagen hybrid scaffolds in cartilage tissue engineering</article-title>. <source>Biomaterials</source> <year>2010</year>; <volume>31</volume>: <fpage>2141</fpage>–<lpage>2152</lpage>.</citation>
</ref>
<ref id="bibr26-0883911513484205">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>G</given-names></name>
<name><surname>Sato</surname><given-names>T</given-names></name>
<name><surname>Ushida</surname><given-names>T</given-names></name><etal/>
</person-group>. <article-title>The use of a novel PLGA fiber/collagen composite web as a scaffold for engineering of articular cartilage tissue with adjustable thickness</article-title>. <source>J Biomed Mater Res A</source> <year>2003</year>; <volume>67</volume>: <fpage>1170</fpage>–<lpage>1180</lpage>.</citation>
</ref>
<ref id="bibr27-0883911513484205">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Freed</surname><given-names>LE</given-names></name>
<name><surname>Marquis</surname><given-names>JC</given-names></name>
<name><surname>Vunjak-Novakovic</surname><given-names>G</given-names></name><etal/>
</person-group>. <article-title>Composition of cell-polymer cartilage implants</article-title>. <source>Biotechnol Bioeng</source> <year>1994</year>; <volume>43</volume>: <fpage>605</fpage>–<lpage>614</lpage>.</citation>
</ref>
<ref id="bibr28-0883911513484205">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gugala</surname><given-names>Z</given-names></name>
<name><surname>Gogolewski</surname><given-names>S</given-names></name>
</person-group>. <article-title>In vitro growth and activity of primary chondrocytes on a resorbable polylactide three-dimensional scaffold</article-title>. <source>J Biomed Mater Res</source> <year>2000</year>; <volume>49</volume>: <fpage>183</fpage>–<lpage>191</lpage>.</citation>
</ref>
<ref id="bibr29-0883911513484205">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cottle</surname><given-names>MH</given-names></name>
</person-group>. <article-title>Nasal surgery in children</article-title>. <source>Eye Ear Nose Throat Mon</source> <year>1951</year>; <volume>30</volume>: <fpage>32</fpage>–<lpage>38</lpage>.</citation>
</ref>
<ref id="bibr30-0883911513484205">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bujía</surname><given-names>J</given-names></name>
</person-group>. <article-title>Determination of the viability of crushed cartilage grafts: clinical implications for wound healing in nasal surgery</article-title>. <source>Ann Plast Surg</source> <year>1994</year>; <volume>32</volume>: <fpage>261</fpage>–<lpage>265</lpage>.</citation>
</ref>
<ref id="bibr31-0883911513484205">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Z</given-names></name>
<name><surname>Perrault</surname><given-names>DF</given-names><suffix>Jr</suffix></name>
<name><surname>Pankratov</surname><given-names>MM</given-names></name><etal/>
</person-group>. <article-title>Endoscopic laser-assisted reshaping of collapsed tracheal cartilage: a laboratory study</article-title>. <source>Ann Otol Rhinol Laryngol</source> <year>1996</year>; <volume>105</volume>: <fpage>176</fpage>–<lpage>181</lpage>.</citation>
</ref>
<ref id="bibr32-0883911513484205">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Helidonis</surname><given-names>E</given-names></name>
<name><surname>Sobol</surname><given-names>E</given-names></name>
<name><surname>Kavvalos</surname><given-names>G</given-names></name><etal/>
</person-group>. <article-title>Laser shaping of composite cartilage grafts</article-title>. <source>Am J Otolaryngol</source> <year>1993</year>; <volume>14</volume>: <fpage>410</fpage>–<lpage>412</lpage>.</citation>
</ref>
<ref id="bibr33-0883911513484205">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Protsenko</surname><given-names>DE</given-names></name>
<name><surname>Ho</surname><given-names>K</given-names></name>
<name><surname>Wong</surname><given-names>BJ</given-names></name>
</person-group>. <article-title>Stress relaxation in porcine septal cartilage during electromechanical reshaping: mechanical and electrical responses</article-title>. <source>Ann Biomed Eng</source> <year>2006</year>; <volume>34</volume>: <fpage>455</fpage>–<lpage>464</lpage>.</citation>
</ref>
<ref id="bibr34-0883911513484205">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Manuel</surname><given-names>CT</given-names></name>
<name><surname>Foulad</surname><given-names>A</given-names></name>
<name><surname>Protsenko</surname><given-names>DE</given-names></name><etal/>
</person-group>. <article-title>Needle electrode-based electromechanical reshaping of cartilage</article-title>. <source>Ann Biomed Eng</source> <year>2010</year>; <volume>38</volume>: <fpage>3389</fpage>–<lpage>3397</lpage>.</citation>
</ref>
<ref id="bibr35-0883911513484205">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ahmed</surname><given-names>TA</given-names></name>
<name><surname>Hincke</surname><given-names>MT</given-names></name>
</person-group>. <article-title>Strategies for articular cartilage lesion repair and functional restoration</article-title>. <source>Tissue Eng Part B Rev</source> <year>2010</year>; <volume>16</volume>: <fpage>305</fpage>–<lpage>329</lpage>.</citation>
</ref>
<ref id="bibr36-0883911513484205">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Onyekwelu</surname><given-names>I</given-names></name>
<name><surname>Goldring</surname><given-names>MB</given-names></name>
<name><surname>Hidaka</surname><given-names>C</given-names></name>
</person-group>. <article-title>Chondrogenesis, joint formation, and articular cartilage regeneration</article-title>. <source>J Cell Biochem</source> <year>2009</year>; <volume>107</volume>: <fpage>383</fpage>–<lpage>392</lpage>.</citation>
</ref>
<ref id="bibr37-0883911513484205">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>M</given-names></name>
<name><surname>Przyborowski</surname><given-names>M</given-names></name>
<name><surname>Berthiaume</surname><given-names>F</given-names></name>
</person-group>. <article-title>Stem cells for skin tissue engineering and wound healing</article-title>. <source>Crit Rev Biomed Eng</source> <year>2009</year>; <volume>37</volume>: <fpage>399</fpage>–<lpage>421</lpage>.</citation>
</ref>
<ref id="bibr38-0883911513484205">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>MacNeil</surname><given-names>S</given-names></name>
</person-group>. <article-title>Progress and opportunities for tissue-engineered skin</article-title>. <source>Nature</source> <year>2007</year>; <volume>445</volume>: <fpage>874</fpage>–<lpage>880</lpage>.</citation>
</ref>
<ref id="bibr39-0883911513484205">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sachlos</surname><given-names>E</given-names></name>
<name><surname>Czernuszka</surname><given-names>JT</given-names></name>
</person-group>. <article-title>Making tissue engineering scaffolds work. Review: the application of solid freeform fabrication technology to the production of tissue engineering scaffolds</article-title>. <source>Eur Cell Mater</source> <year>2003</year>; <volume>5</volume>: <fpage>29</fpage>–<lpage>40</lpage>.</citation>
</ref>
<ref id="bibr40-0883911513484205">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vaz</surname><given-names>CM</given-names></name>
<name><surname>van Tuijl</surname><given-names>S</given-names></name>
<name><surname>Bouten</surname><given-names>CV</given-names></name><etal/>
</person-group>. <article-title>Design of scaffolds for blood vessel tissue engineering using a multi-layering electrospinning technique</article-title>. <source>Acta Biomater</source> <year>2005</year>; <volume>1</volume>: <fpage>575</fpage>–<lpage>582</lpage>.</citation>
</ref>
<ref id="bibr41-0883911513484205">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kidoaki</surname><given-names>S</given-names></name>
<name><surname>Kwon</surname><given-names>IK</given-names></name>
<name><surname>Matsuda</surname><given-names>T</given-names></name>
</person-group>. <article-title>Mesoscopic spatial designs of nano- and microfiber meshes for tissue-engineering matrix and scaffold based on newly devised multilayering and mixing electrospinning techniques</article-title>. <source>Biomaterials</source> <year>2005</year>; <volume>26</volume>: <fpage>37</fpage>–<lpage>46</lpage>.</citation>
</ref>
<ref id="bibr42-0883911513484205">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Waldman</surname><given-names>SD</given-names></name>
<name><surname>Grynpas</surname><given-names>MD</given-names></name>
<name><surname>Pilliar</surname><given-names>RM</given-names></name><etal/>
</person-group>. <article-title>The use of specific chondrocyte populations to modulate the properties of tissue-engineered cartilage</article-title>. <source>J Orthop Res</source> <year>2003</year>; <volume>21</volume>: <fpage>132</fpage>–<lpage>138</lpage>.</citation>
</ref>
<ref id="bibr43-0883911513484205">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rogers</surname><given-names>BA</given-names></name>
<name><surname>Murphy</surname><given-names>CL</given-names></name>
<name><surname>Cannon</surname><given-names>SR</given-names></name><etal/>
</person-group>. <article-title>Topographical variation in glycosaminoglycan content in human articular cartilage</article-title>. <source>J Bone Joint Surg Br</source> <year>2006</year>; <volume>88</volume>: <fpage>1670</fpage>–<lpage>1674</lpage>.</citation>
</ref>
<ref id="bibr44-0883911513484205">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mouw</surname><given-names>JK</given-names></name>
<name><surname>Case</surname><given-names>ND</given-names></name>
<name><surname>Guldberg</surname><given-names>RE</given-names></name><etal/>
</person-group>. <article-title>Variations in matrix composition and GAG fine structure among scaffolds for cartilage tissue engineering</article-title>. <source>Osteoarthritis Cartilage</source> <year>2005</year>; <volume>13</volume>: <fpage>828</fpage>–<lpage>836</lpage>.</citation>
</ref>
<ref id="bibr45-0883911513484205">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Santo</surname><given-names>VE</given-names></name>
<name><surname>Gomes</surname><given-names>ME</given-names></name>
<name><surname>Reis</surname><given-names>RL</given-names></name><etal/>
</person-group>. <article-title>Encapsulation of adipose-derived stem cells and transforming growth factor-β1 in carrageenan-based hydrogels for cartilage tissue engineering</article-title>. <source>J Bioact Compat Polym</source> <year>2011</year>; <volume>26</volume>: <fpage>493</fpage>–<lpage>507</lpage>.</citation>
</ref>
<ref id="bibr46-0883911513484205">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bueno</surname><given-names>EM</given-names></name>
<name><surname>Bilgen</surname><given-names>B</given-names></name>
<name><surname>Barabino</surname><given-names>GA</given-names></name>
</person-group>. <article-title>Hydrodynamic parameters modulate biochemical, histological, and mechanical properties of engineered cartilage</article-title>. <source>Tissue Eng Part A</source> <year>2009</year>; <volume>15</volume>: <fpage>773</fpage>–<lpage>785</lpage>.</citation>
</ref>
<ref id="bibr47-0883911513484205">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mahmoudifar</surname><given-names>N</given-names></name>
<name><surname>Doran</surname><given-names>PM</given-names></name>
</person-group>. <article-title>Tissue engineering of human cartilage and osteochondral composites using recirculation bioreactors</article-title>. <source>Biomaterials</source> <year>2005</year>; <volume>26</volume>: <fpage>7012</fpage>–<lpage>7024</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>